{"id":521319,"date":"2021-08-02T09:04:02","date_gmt":"2021-08-02T13:04:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/abbotts-freestyle-libre-2-ios-app-cleared-in-u-s-providing-a-seamless-digital-experience-to-simplify-diabetes-management\/"},"modified":"2021-08-02T09:04:02","modified_gmt":"2021-08-02T13:04:02","slug":"abbotts-freestyle-libre-2-ios-app-cleared-in-u-s-providing-a-seamless-digital-experience-to-simplify-diabetes-management","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/abbotts-freestyle-libre-2-ios-app-cleared-in-u-s-providing-a-seamless-digital-experience-to-simplify-diabetes-management\/","title":{"rendered":"Abbott’s FreeStyle\u00ae Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management"},"content":{"rendered":"
\n

– FreeStyle Libre 2 iOS app is the only sensor-based glucose monitoring app that allows users to check their glucose with a compatible iPhone[1] every minute with optional real-time glucose alarms[2]<\/h2>\n

– The FreeStyle Libre 2 app enables kids (ages 4 and older) and adults to easily share their glucose data with parents and other caregivers via the LibreLinkUp[3] app<\/h2>\n

– Free to download on the App Store, the FreeStyle Libre 2 iOS app will be available soon<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

ABBOTT PARK, Ill., Aug. 2, 2021<\/span> \/PRNewswire\/ —\u00a0Abbott announced today that the U.S. Food and Drug Administration (FDA) has cleared the FreeStyle\u00ae<\/sup> Libre 2 iOS application for use with compatible iPhones1<\/sup>, providing a comprehensive digital offering for its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system<\/a>. Providing breakthrough technology that is accessible and affordable4<\/sup>, the FreeStyle Libre portfolio is the number one continuous glucose monitoring (CGM) system worldwide5<\/sup>\u00a0and most prescribed in the U.S.6<\/sup>, changing the lives of nearly 3.5 million people across more than 50 countries including 1 million users in the U.S. <\/p>\n

\n

\n
\n \"Now
\n <\/a>\n <\/p>\n<\/p><\/div>\n

Approved for adults and children (4 and older) with diabetes, the new FreeStyle Libre 2 app creates a seamless experience for users and healthcare professionals. The app enables users to get glucose readings directly on their iPhones without the use of a reader. A key benefit of the app is the ability for caregivers to remotely monitor their loved one’s glucose readings and get real-time alarms via the LibreLinkUp app<\/a>.7<\/sup>\u00a0<\/p>\n

“The demands of living with diabetes<\/a>\u00a0can be overwhelming, and there’s a critical need to improve the way people with diabetes manage their condition \u2013 easily, affordably, accurately \u2013 and in a way that seamlessly fits into their everyday lives,” said Jared Watkin,\u00a0senior vice president, Diabetes Care, Abbott. “The FreeStyle Libre 2 iOS app streamlines how people manage their diabetes on their iPhones \u2013 empowering users with the information they need 24\/7 while improving their health on the go.”\u00a0<\/p>\n

According to a recent Gallup poll, 1 in 5 Americans currently tracks health statistics using a mobile app.8<\/sup>\u00a0Free to download on the iOS App Store soon, the FreeStyle Libre 2 app will offer personalized, up-to-the-minute glucose data for people with diabetes who are using FreeStyle Libre 2 glucose sensors. By scanning the sensor with the \u00a0FreeStyle Libre 2 app, users will get their current glucose reading and trend arrow which can help them determine how food, exercise and other lifestyle factors impact diabetes management. <\/p>\n

With a 14-day wear time, FreeStyle Libre 2 is the longest-lasting iCGM sensor currently on the market.9<\/sup>\u00a0Available at pharmacies\u00a0at a fraction of the cost of other CGM systems,10<\/sup>\u00a0the FreeStyle Libre 2 system is widely accessible to people with diabetes. Integrated features include:<\/p>\n